Pandi, Sudha Priya Soundara
Shattock, Michael J.
Hendry, Bruce M.
Sharpe, Claire C.
Funding for this research was provided by:
Kidney Research UK (RP39/2014, RP39/2014, RP39/2014)
British Heart Foundation (RG/12/4/29426)
Article History
Received: 5 August 2021
Accepted: 7 June 2022
First Online: 16 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: BMH is an employee and stock holder of Travere Therapeutics. CCS has received consulting fees from Novartis Pharmaceuticals, Vifor Pharmaceuticals and Travere therapeutics. MJS and SPSP declare no potential conflict of interest.